CollPlant, an Israeli regenerative medicine company focused on 3D bioprinting of tissues and organs, signed a license, development and commercialization agreement with United Therapeutics Corporation of Maryland for 3D bioprinted lung transplants.
{iframe}https://www.israel21c.org/3d-bioprinted-lungs-to-be-available-for-global-transplants/{/iframe}